The treatment of vesicoureteral reflux in children by endoscopic sub-mucosal intra-ureteral injection of dextranomer/hyaluronic acid: A case-series, multi-centre study
Background: Vesicoureteral reflux is a risk factor for progressive renal damage. In addition to long-term antibiotic prophylaxis and open surgical re-implantation, endoscopic sub-mucosal intra-ureteral injection of implant material is a therapeutic alternative that gained a world-wide preference....
Main Author: | Osama Bawazir |
---|---|
Format: | Article |
Language: | English |
Published: |
Electronic Physician
2017-04-01
|
Series: | Electronic Physician |
Subjects: | |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459285/ |
Similar Items
-
Endoscopic treatment of vesicoureteral reflux with dextranomer/ hyaluronic acid-our experience
by: Prasad Mylarappa, et al.
Published: (2013-07-01) -
Mid-Term Safety and Efficacy of the Modified Double Hydrodistention Implantation Technique (HIT), Termed Systematic Multi-Site HIT (SMHIT), for Patients with Primary Vesicoureteral Reflux
by: Nakamura S, et al.
Published: (2020-10-01) -
Asymptomatic bilateral delayed ureteral obstruction following dextranomer/hyaluronic acid copolymer (Deflux) injection for vesicoureteral reflux.: A case report
by: Sayaka Hoshino, et al.
Published: (2021-03-01) -
Endoscopic treatment of vesico-ureteral reflux: Experience of 99 ureteric moieties
by: Minu Bajpai, et al.
Published: (2013-01-01) -
A rare and unusual complication of the STING procedure
by: Joseph Santiapillai, et al.
Published: (2020-09-01)